Symbol Name ID |
Fah
fumarylacetoacetate hydrolase MGI:95482 |
Darker colors indicate more annotations |
Human Phenotypes | Hypophosphatemic rickets |
Hypertyrosinemia |
Hypermethioninemia |
Elevated circulating alpha-fetoprotein concentration |
Elevated circulating hepatic transaminase concentration |
Hypoglycemia |
Metabolic acidosis |
Renal Fanconi syndrome |
Fever |
Elevated urinary delta-aminolevulinic acid |
Elevated urinary succinylacetone level |
Ascites |
Disease(s) Associated with FAH | ||||||||||||
tyrosinemia type I |
Mouse Phenotypes | abnormal amino acid level |
abnormal circulating amino acid level |
increased circulating creatinine level |
increased circulating tyrosine level |
aminoaciduria |
increased circulating bilirubin level |
hypoglycemia |
abnormal circulating aspartate transaminase level |
increased circulating aspartate transaminase level |
edema |
increased alpha-fetoprotein level |
abnormal urine homeostasis |
increased susceptibility to xenobiotic induced morbidity/mortality |
increased susceptibility to injury |
|
Availability | Mouse Genotype | ||||||||||||||
Fah1R/Fah1R | |||||||||||||||
Fah2R/Fah2R | |||||||||||||||
Fahem1(IMPC)Mbp/Fahem1(IMPC)Mbp | |||||||||||||||
Fahtm1Mgo/Fahtm1Mgo |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 05/14/2024 MGI 6.23 |
|
|